About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
2021 Virtual KU Hematology and Medical Oncology Review
https://www.kucancercenter.org/
Videos
Event
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
ASCO 2021 Review of the OlympiA Trial for High-Risk EBC: Do Adjuvant PARPi Improve Outcomes?
By
2021 Virtual KU Hematology and Medical Oncology Review
FEATURING
Qamar Khan
By
2021 Virtual KU Hematology and Medical Oncology Review
FEATURING
Qamar Khan
0 views
July 22, 2021
Comments
0
Login to view comments.
Click here to Login
Videos
43:11
2021 Virtual KU Hematology and Medical Oncology Review
2021 Advances in Metastatic Sarcoma: GIST & Ripretinib, Synovial…
Feat.
B. Van Tine
25:06
2021 Virtual KU Hematology and Medical Oncology Review
ASCO 2021 Survivorship Highlights: Remote Symptom Monitoring, Inpati…
Feat.
E. Wulff-Burchfield
30:04
2021 Virtual KU Hematology and Medical Oncology Review
2021 Updates in HNSCC: Expert Overview of Recent Clinical Trials
Feat.
B. Burtness
09:13
2021 Virtual KU Hematology and Medical Oncology Review
ASCO 2021 Updates in Head and Neck Cancers: Advanced NPC, HPV-Relate…
Feat.
B. Burtness
18:15
2021 Virtual KU Hematology and Medical Oncology Review
KUMC Highlights on mCRC: Recent Data on Changes in the SoC
Feat.
W. Sun
06:25
2021 Virtual KU Hematology and Medical Oncology Review
2021 KUMC Metastatic Prostate Cancer Updates: 177Lu-PSMA-617 in mCRP…
Feat.
S. Abbasi
08:08
2021 Virtual KU Hematology and Medical Oncology Review
2021 Developments in RCC & UC: Pembro for ccRCC, Sacituzumab Gov…
Feat.
S. Abbasi
15:17
2021 Virtual KU Hematology and Medical Oncology Review
2021 Advances in CML: Prognostic Scores, Treatment Goals, 1L & B…
Feat.
A. Yacoub
05:01
2021 Virtual KU Hematology and Medical Oncology Review
2021 Advances in Myelofibrosis: Parsaclisib + Ruxolitinib Combinatio…
Feat.
A. Yacoub
10:52
2021 Virtual KU Hematology and Medical Oncology Review
2021 KUMC NDMM Updates: Assessing Current Trials for Treatment, Indu…
Feat.
A. Abdallah
07:17
2021 Virtual KU Hematology and Medical Oncology Review
2021 KUMC Updates on Triple R/R MM: Does Ide-Cel Improve Overall Res…
Feat.
A. Abdallah
27:42
2021 Virtual KU Hematology and Medical Oncology Review
CAR T-Cell and CRISPR in Hematologic Malignancies: Continuing Revolu…
Feat.
J. McGuirk
10:44
2021 Virtual KU Hematology and Medical Oncology Review
ASCO 2021 Highlights on TNBC: Durvalumab + Neoadjuvant Therapy in Ea…
Feat.
Q. Khan
08:59
2021 Virtual KU Hematology and Medical Oncology Review
ASCO 2021 Review of the OlympiA Trial for High-Risk EBC: Do Adjuvant…
Feat.
Q. Khan
10:17
2021 Virtual KU Hematology and Medical Oncology Review
ASCO 2021 Updates on De-Escalation Strategies in BC: Talazoparib for…
Feat.
Q. Khan
